180 Life Sciences and University of Oxford Announce
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in nodule size at multiple time...
Source: globenewswire.com
Stay updated with breaking news from Randomised Dose Response Proof. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in nodule size at multiple time...